Table 5 Most frequent adverse events after 28 days of treatment
Adverse events | AL | DHA-PPQ | P-value* |
|---|---|---|---|
(N = 157) | (N = 187) | ||
Patients with at least one adverse event | 87 (55.4) | 112 (59.9) | 0.443 |
Abdominal pain | 17 (10.8) | 10 (5.3) | 0.071 |
Chills | 12 (7.6) | 15 (8.0) | 1.0 |
Cough | 60 (38.2) | 71 (38.0) | 1.0 |
Diarrhoea | 11 (7.0) | 8 (4.3) | 0.345 |
Headache | 16 (10.2) | 35 (18.7) | 0.033 |
Vomit | 4 (2.5) | 6 (3.2) | 0.760 |
Ear pain | 3 (1.9) | 2 (1.1) | 0.663 |
Running nose | 19 (12.1) | 41 (21.9) | 0.022 |
Skin rash | 1 (0.6) | 2 (1.1) | 1.0 |
Shortness of breath | 1 (0.6) | 2 (1.1) | 1.0 |
Fits | 1 (0.6) | 2 (1.1) | 1.0 |
Stiff neck | 1 (0.6) | 1 (0.5) | 1.0 |